Short‐term toxicity assessment of combined use of zidovudine, lamivudine and lopinavir/ritonavir in vitro and in vivo

Author:

Wen Pingjing1ORCID,Ge Xianmin2,Wang Yanwu2,Ge Yun3,Lan Guanghua2,Li Bin2,Qin Guangqiu1,Zhu Qiuying2,Chen Huanhuan2,Zhu Jinhui2,Qin Huiyan2,Yang Hui2,Luo Hailan2,Gao Yuqiu1,Meng Qin2,Luo Liuhong2,Liu Shuaifeng2,Wu Xiuling2,Li Shanshan2,Deng Yueqin2

Affiliation:

1. Department of Preventive Medicine Guangxi University of Chinese Medicine Nanning China

2. Institute of Toxicology Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention Nanning China

3. The Second People's Hospital of Guilin Guilin China

Abstract

AbstractIntroductionA combination of zidovudine (AZT), lamivudine (3TC) and lopinavir/ritonavir (LPV/r) is one of the most effective drugs for preventing mother‐to‐child transmission (PMTCT) of HIV. However, limited information is available regarding its systemic toxicity. This study aimed to investigate its potential toxicity.MethodAn acute oral toxicity test was conducted to assess the potential acute toxicity of AZT + 3TC + LPV/r. Bacterial reverse mutation, mammalian erythrocyte micronucleus and mouse spermatogonia chromosomal aberration tests were conducted to assess its potential genotoxicity. A 28‐day feeding test was conducted to assess the potential subacute toxicity.ResultsIn mice, the LD50 of the AZT + 3TC + LPV/r mixture was greater than 2000 mg/kg body weight (BW). The rate of micronucleated polychromatic erythrocytes (PCEs) increased in a dose‐dependent manner in mice (P < 0.01). After treatment with AZT + 3TC + LPV/r for 28 days, the BW gain of male and female rats in the high‐dose group was lower than that in the control group (P < 0.05); the relative weights of the liver, kidney, spleen and brain increased (P < 0.05); and pathological abnormalities appeared in the thyroid and spleen of male and female rats in the high‐dose group. The haemoglobin (HGB) and red blood cells (RBCs) count in male and female rats decreased, but the white blood cells (WBCs) and lymphocyte apoptosis rates in male and female rats in the high‐dose group increased (P < 0.05). The total protein, albumin, cholesterol and blood glucose levels of male and female rats in the high‐dose group were significantly decreased (P < 0.05). The alanine aminotransferase (ALT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), creatinine (Cr) and blood urea nitrogen (BUN) levels of male and female rats in the medium‐ and high‐dose groups increased significantly (P < 0.05).ConclusionThe results suggest that AZT + 3TC + LPV/r may exhibit genotoxicity and subacute toxicity under experimental conditions.

Funder

National Major Science and Technology Projects of China

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Reference51 articles.

1. WHO.Summary of the global HIV epidemic 2020[DB/OL]. [2021‐07].https://www.who.int/data/gho/data/themes/hiv-aids

2. Joint United Nations Programme on HIV/AIDS. President's emergency plan for AIDS relief (PEPFAR) and partners.Start Free Stay Free AIDS Free: A super fast‐track framework for ending AIDS among children adolescents and young women by 2020. [2021‐10‐11].https://free.unaids.org/

3. WHO.New data on the prevention of mother to child transmission of HIV and their policy implications: conclusions and recommendations.2001.http://catalogue.safaids.net/publications/new-data-prevention-mother-child-transmission-hiv-and-their-policy-implications-concl-0

4. Progress in the prevention of mother‐to‐child transmission of AIDS (in Chinese);Li Y;J Kunming Med Univ,2012

5. WHO.Estimated pregnant women living with HIV who received antiretroviral medicine for preventing mother‐to‐child transmission (%) [DB/OL]. [2021‐10‐11].https://www.who.int/data/gho/data/indicators/indicator-details/GHO/estimated-percentage-of-pregnant-women-living-with-hiv-who-received-antiretrovirals-for-preventing-mother-to-child-transmission

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3